Featured Videos |view more
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
Featured Articles and Documents |view more
Using deep learning, a subset of artificial intelligence involving statistical computation, MUSC Health neurologists have developed a new method that may one day help both patients with medication-refractory epilepsy and their physicians ...
Revealing possible links through genes that control brain wiring
MUSC Health Neurosciences ranks first in the Southeast and second in the country in National Institutes of Health neuroscience research funding. It places researchers and clinicians at each other’s side in an effort to realize the clinical promise of cutting-edge research. As a consistent leader in neuroscience advances, MUSC Health is: